Debt-to-equity of Eton Pharmaceuticals, Inc. from 30 Jun 2019 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Eton Pharmaceuticals, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2019 to 30 Sep 2025.
  • Eton Pharmaceuticals, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 282%, a 144% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Eton Pharmaceuticals, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 282% +166% +144% 30 Sep 2025
Q2 2025 235% +130% +123% 30 Jun 2025
Q1 2025 191% +97% +104% 31 Mar 2025
Q4 2024 152% +56% +58% 31 Dec 2024
Q3 2024 116% +23% +25% 30 Sep 2024
Q2 2024 105% +11% +12% 30 Jun 2024
Q1 2024 94% +2% +1.8% 31 Mar 2024
Q4 2023 96% +13% +16% 31 Dec 2023
Q3 2023 92% +21% +29% 30 Sep 2023
Q2 2023 94% +27% +40% 30 Jun 2023
Q1 2023 92% +33% +56% 31 Mar 2023
Q4 2022 82% +30% +57% 31 Dec 2022
Q3 2022 72% +18% +34% 30 Sep 2022
Q2 2022 67% +3% +4.8% 30 Jun 2022
Q1 2022 59% -20% -26% 31 Mar 2022
Q4 2021 52% -43% -45% 31 Dec 2021
Q3 2021 53% -50% -48% 30 Sep 2021
Q2 2021 64% +11% +20% 30 Jun 2021
Q1 2021 79% +48% +152% 31 Mar 2021
Q4 2020 95% +73% +330% 31 Dec 2020
Q3 2020 104% +92% +810% 30 Sep 2020
Q2 2020 54% +32% +144% 30 Jun 2020
Q1 2020 32% 31 Mar 2020
Q4 2019 22% 31 Dec 2019
Q3 2019 11% 30 Sep 2019
Q2 2019 22% 30 Jun 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.